Manila Times Business
Ascentage Pharma to Present Data from Multiple Trials, Including an Oral Presentation of APG-5918 at ASH 2026
ROCKVILLE, Md., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development, and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that multiple clinical and preclinical studies have been selected at the 68th American Society of Hematology (ASH) Annual Meeting, involving four of the Company’s pro
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
The Two-Year Brand Project Is Over: EducationDynamics Launches Process That Puts New Brand in Market in 90 Days
Just now
FP Trading Launches Mobile App for Analysing, Trading and Managing Accounts
Just now
Perimenopause Gets a Seat at the Table: Pemi Launches Supper Club Series With Inaugural NYC Gathering
Just now
Five Star Bancorp Appoints Banking Veteran Christopher D. Myers to its Board of Directors
Just now